MNMona Nourbakhsh

Mona Nourbakhsh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mona Nourbakhsh has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Maryam Razzaghy-Azar

    Department of Pediatrics Endocrinology and Metabolism, School of Medicine, Ali Asghar Children's Hospital Iran University of Medical Sciences Tehran Iran

    4 shared publications
  • Mitra Nourbakhsh

    Department of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Mitra Nourbakhsh

    Finetech in Medicine Research Center Iran University of Medical Sciences Tehran Iran

    3 shared publications
  • Maryam Razzaghy-Azar

    Metabolic Disorders Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran; H.Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Abolfazl Golestani

    Department of Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Amir Hossein Doustimotlagh

    Department of Clinical Biochemistry, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran

    1 shared publication

Latest Publications

  • Open Access

    Relationship between vitamin D levels in mother’s blood and neonatal umbilical cord with jaundice in neonates

    by Zahra Sadr, Mona Nourbakhsh, Majid Bakhshizade, Forough Mokhtari, Maryam Biglari Abhari

    Introduction: In neonates, jaundice is the result of an imbalance between the production and conjugation of bilirubin. Overall, about 60% of full-term neonates experience jaundice in the first week of life. Metabolism of bilirubin and vitamin D occurs in two separate pathways, but because one stage of their production happens in liver, they may affect each other. Objectives: Diagnostic and therapeutic assays are based only on the opinion of obstetricians and gynecologists. The possible results of this study may help to explain preventive methods. In this study, we will evaluate the relationship between serum levels of vitamin D in the mother’s blood and the baby’s umbilical cord with the occurrence of neonatal jaundice. Patients and Methods: This prospective study (cohort) was performed on 110 mothers and their newborns in Firoozabadi hospital in Shahr-e Ray. The sampling method was non-probability convenience. Data including maternal age, nationality, gravidity, gestational age, maternal diseases such as chronic the liver and kidney disease, diabetes mellitus, hypertension and the use of anticonvulsant drugs were obtained from the maternity delivery records and mothers who did not meet the inclusion criteria were excluded at first. Maternal blood samples during labor and neonatal umbilical cord samples were used for assaying the serum levels of 25-hydroxy vitamin D, calcium (Ca) and phosphorus (P), alkaline phosphatase (ALP). All neonates visited for jaundice on days 7 and 14 after birth and tested for bilirubin levels if jaundice was observed. Results: There was no significant difference between neonates with normal and abnormal vitamin D levels in terms of jaundice on day 7 (P=0.571). Additionally, there was not a significant relationship between mothers with normal and abnormal vitamin D levels in terms of jaundice on day 7 in their neonates (P=0.587). However, a statistically significant relationship between normal vitamin D levels in mothers with jaundice in their neonates on day 14 (P=0.003) was detected. There was a significant relationship between normal maternal vitamin D with the incidence of neonatal jaundice on day 14 (relative risk = 0.32). In addition, evaluation of the relationship between normal and abnormal vitamin D levels in neonates with 14th day jaundice revealed no statistically significant relationship between the two groups of normal and abnormal (P=0.1). Mean serum ALP concentration in mothers of neonates who did not develop jaundice was significantly higher than mothers of neonates with severe jaundice (bilirubin >15 mg/ dL) (P=0.02). First minute Apgar score in neonates who had no jaundice or developed mild jaundice was significantly higher than neonates with severe jaundice (bilirubin >15 mg/dL) (P=0.026). Conclusion: Overall, in this study, no significant relationship was observed between neonatal 7th day jaundice with maternal and neonatal vitamin D levels. There was a significant relationship between maternal normal serum vitamin D levels with neonatal 14th day jaundice.


  • Open Access

    Sestrin2 and Beclin1 levels in Polycystic Ovary Syndrome

    by Vahid Saeedi, Mona Nourbakhsh, Mitra Nourbakhsh, Ladan Haghighi, Leila Kamalzadeh, Samira Ezzati Mobasser, Maryam Razzaghy‐Azar

    Background: Sestrin2 and beclin1 are two newly found proteins that have essential roles in autophagy. This study attempted to evaluate the plasma concentrations of sestrin2 and beclin1 in women with polycystic ovary syndrome (PCOS) and healthy controls and to explore the clinical value of these proteins as novel biomarkers for PCOS.Methods: In this case‐control study, plasma levels of sestrin2 and beclin1, fasting blood sugar (FBS), lipid profile, insulin, and androgens were evaluated in 63 women (31 patients and 32 controls). Sestrin2 and beclin1 levels were determined using enzyme‐linked immunosorbent assay (ELISA). Descriptive statistics, correlation coefficients, logistic regression, and ROC curve analyses were used in this study.Results: Plasma sestrin2 levels of the subjects with PCOS (40.74 [24.39–257.70]) were significantly lower than those of healthy subjects (255.78 [25.46–528.66]; p‐value = 0.040). ROC curve analysis showed that a cutoff value of 420.5 ng/L had an appropriate sensitivity (83.87%) and specificity (46.88%) for discriminating individuals with and without PCOS, with the area under the curve (95% CI) of 0.648 (0.518 to 0.764), p = 0.036. There were no statistically significant differences between the two groups concerning plasma levels of beclin1, biochemical parameters, blood pressure, and anthropometric features.Conclusion: Our findings highlight the dysregulation of sestrin2 as a marker of autophagy in PCOS and its potential usefulness as a novel biomarker for PCOS. Further research is needed to better understand the role of this protein in the pathophysiology of PCOS and its value as a diagnostic tool for the evaluation of PCOS patients.


  • Open Access

    Angiopoietin‐Like Proteins 2 and 3 in Children and Adolescents with Obesity and Their Relationship with Hypertension and Metabolic Syndrome

    by Zahra Arab Sadeghabadi, Mitra Nourbakhsh, Mohammad Alaee, Mona Nourbakhsh, Seyedeh Sara Ghorbanhosseini, Roya Sharifi, Maryam Razzaghy-Azar

    Background . Angiopoietin‐like protein 2 (ANGPTL2) is one of the adipocyte‐derived inflammatory factors which connects obesity to insulin resistance. ANGPTL3 has a direct role in regulation of lipid metabolism. The objective of this study was to evaluate ANGPTL2 and ANGPTL3 in childhood obesity and their relationship with metabolic syndrome. Methods . 70 children and adolescents, 35 obese and 35 normal‐weight subjects, were enrolled in this research after complete clinical examination and anthropometric evaluations. Serum ANGPTL2 and ANGPTL3 and insulin were measured by enzyme‐linked immunosorbent assay (ELISA). Homeostatic model assessment of insulin resistance (HOMA‐IR) was calculated and used to estimate insulin resistance (IR). Colorimetric methods were used for the assessment of fasting plasma glucose (FPG), LDL‐C, HDL‐C, total cholesterol (TC), and triglyceride (TG). Results . The levels of ANGPTL2 and ANGPTL3 were significantly higher in obese subjects than those in controls, but they did not differ significantly in subjects with or without IR. ANGPTL3 was found to be significantly elevated in obese children with metabolic syndrome (MetS) in comparison with those without MetS. Both of the studied ANGPTLs were positively correlated with BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), TC, and LDL‐C. The correlation between ANGPTL3 and either TC or LDL‐C remained significant after adjusting for BMI. Conclusion . Serum ANGPTL2 and ANGPTL3 were elevated in obesity and associated with blood pressure and indices of metabolic syndrome, suggesting that they might be involved in the advancement of obesity‐related hypertension and metabolic syndrome.


  • A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride

    by Maryam Razzaghy‐Azar, Mitra Nourbakhsh, Mona Nourbakhsh

    Summary: Background: Cyproheptadine HCl (CyproH) is an appetite‐stimulating drug and while it was prescribed for a patient with growth hormone insensitivity syndrome (GHIS) for increasing appetite, his height growth was surprisingly increased. Therefore, the aim of this study was to investigate the effect of CyproH on growth parameters of the patients with GHIS.Patients and design: Twenty patients were enrolled in two prospective cohorts at two different times. Fifteen cases were observed for 1.17 ± 1.3 years without treatment (observation period, OP). Then, CyproH was administered for 2.2 ± 2.7 years (treatment period, TP), and growth parameters were compared within these two periods. Five patients who did not receive any treatment for 1‐8.24 years (4 ± 2.9) were the control group.Results: Height velocity (HV) increased from 1.88 ± 0.7 to 6.1 ± 0.8 cm/year and HV‐SDS reached from −4.5 ± 0.74 to −0.21 ± 1.2 in OP and TP, respectively (P < .001), whereas HV and HV‐SDS were 2.2 ± 1.1 cm/yr and −4.2 ± 1.2, respectively, in controls (P < .001). Height SDS was −7.0 ± 1.7 and increased to −6 ± 2.2 after treatment (P = .002). Gain in height was 2.3 ± 0.6 SDS in 5 patients who were treated for 5.4 ± 2.8 years. BMI‐SDS was not significantly changed within two time periods and also in cases and controls.Conclusion: CyproH caused height growth in the patients with GHIS, and therefore, this treatment can be considered as an alternative option to IGF‐I injection.


  • Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto’s thyroiditis and hypothyroidism

    by Mitra Nourbakhsh, Fatemeh Ahmadpour, Behnam Chahardoli, Zahra Malekpour-Dehkordi, Mona Nourbakhsh, Seyed Reza Hosseini-Fard, Amirhossein Doustimotlagh, Abolfazl Golestani, Maryam Razzaghy-Azar


  • Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome

    by Mitra Nourbakhsh, Mona Nourbakhsh, Zafar Gholinejad, Maryam Razzaghy-Azar

    Visfatin, also known as nicotinamide phosphoribosyltransferase, is an adipokine that has been implicated in obesity, insulin resistance (IR) and diabetes mellitus. Since obesity profoundly affects serum lipids, insulin, and glucose metabolism, the aim of this study was to evaluate the relationships between visfatin and metabolic parameters in childhood obesity. A total of 73 Iranian children and adolescents (31 controls; 42 obese), between the ages of 7 and 16 years, were selected and clinically evaluated. Serum visfatin, leptin, insulin and adiponectin were measured using ELISA, and insulin resistance was calculated by the Homeostasis Model of Assessment of Insulin Resistance (HOMA-IR). Fasting plasma glucose (FPG), triglyceride (TG), total cholesterol (TC), LDL-C and HDL-C were also measured. Metabolic syndrome (MetS) was determined according to IDF criteria. Obese subjects presented significantly higher levels of insulin, LDL-C, HOMA-IR, and leptin and lower levels of adiponectin. Serum Visfatin was higher in obese children than in the control children, and it was significantly higher in obese children with MetS or IR, compared with obese children without MetS or IR. Visfatin levels showed positive correlations with FPG, insulin, and HOMA-IR, in obese subjects and a negative correlation with adiponectin, but no correlation with leptin. Adiponectin levels were correlated with HDL-C and Insulin levels in obese subjects. Leptin levels were correlated with Body mass index (BMI) but not with metabolic parameters. Visfatin is increased in obese children and adolescents, and has a more prominent association with IR and MetS parameters, compared with leptin and adiponectin.


  • Open Access

    Congenital Adrenal Hyperplasia: Experience in Iranian Patients

    by Maryam Razzaghy Azar, Mona Nourbakhsh, Mitra Nourbakhsh

    Congenital Adrenal Hyperplasia: Experience in Iranian Patients - Journal of Comprehensive Pediatrics - - Iranian Society of Pediatrics